Learn More
Invitrogen™ mirVana™ miRNA Inhibitor, Negative Control #1
Description
mirVana miRNA Inhibitor Negative Control No. 1 is a non-targeting control designed for use in miRNA inhibition experiments. It provides a reliable baseline for evaluating the effects on target gene expression by ensuring minimal off-target effects. Extensively tested in human cell lines and tissues, this control is validated to have no impact on known miRNA functions, making it essential for accurate and consistent gene expression studies. Its properties include high reliability, superior specificity, and versatile use in various experimental setups.
Features of mirVana miRNA Inhibitor Negative Control No. 1 include:
- Reliability—maximum and consistent effect in vitro at low concentration and low toxicity
- Potency—better potency than lead competitor's product
- Superior specificity—the most updated Sanger content
- Versatile use—can be used in vitro and in vivo, offering you consistency throughout your entire research project
What are mirVana miRNA Inhibitors?
mirVana miRNA inhibitors are small, chemically modified single-stranded RNA molecules designed to specifically bind to and inhibit endogenous miRNA molecules and enable miRNA functional analysis by down-regulation of miRNA activity. Positive and negative controls are also available for use along with mirVana miRNA inhibitors in miRNA down-regulation experiments.
Quality control
Each mirVana miRNA Inhibitor is synthesized and purified in state-of-the-art facilities to meet the highest quality standards. Our rigorous quality control procedures include MALDI-TOF mass spectrometry analysis and analytical HPLC to monitor purity. We also assess each miRNA Inhibitor by gel electrophoresis to ensure a premium-quality miRNA inhibitor that is purified and ready for use.
Specifications
Specifications
| Content And Storage | Store at or below -20°C. Do not store in a frost-free freezer. |
| Control Type | Negative Control |
| RNAi Type | miRNA Inhibitor |
| For Use With (Application) | miRNA & Non-Coding RNA Analysis |
| Label or Dye | Unconjugated |
| Product Line | mirVana |
| Product Type | miRNA Inhibitor |
| Purification Method | Purified |
| Quantity | 20 nmol |
| Shipping Condition | Room Temperature |
Frequently Asked Questions (FAQs)
Using TaqMan miRNA assays, you can measure the level of miRNA of interest. If the miRNA is bound to the synthetic anti-miRs and/or mirVana inhibitors transfected, the duplex should not be detected, indicating efficient miRNA inactivation. Please note, this only works when total RNA sample isolated is not heat denatured when RT primer is added, as heat denaturation will result in complex dissociation and subsequent detection of microRNA by TaqMan miRNA assay even when cells have been transfected properly. Please see the protocol for the TaqMan MicroRNA Cells-to-CT kit (Cat. No. 4391848) for more details.
Mimics and inhibitors can be transfected or electroporated into cells using parameters similar to those used for siRNA.
Using mirVana miRNA Mimics- For the following applications, use a cell line that expresses relatively low levels of the mature miRNA of interest.
- Cell density at the time of transfection. In general, 30-70% confluency is recommended.
- Transfection method (traditional or reverse transfection).
- Length of exposure of cells to transfection agent-RNA oligonucleotides complexes.
For many miRNA mimics, maximal activity is achieved after 24 hours, but biological assays may be performed 24-72 hours posttransfection. If you maintain your transfected cells longer than 24 hours, we suggest replacing the existing medium with fresh medium at 24 hours posttransfection, for greater viability of the cells.
Using mirVana miRNA Inhibitors to analyze endogenous miRNA function
For the following applications, use a cell line that expresses relatively high levels of the mature miRNA of interest.
General transfection starting points
mirVana miRNA Mimics and Inhibitors typically work best when transfected at a final concentration of 3-30 nM. Optimization experiments might include a concentration range of 1-100 nM. To increase accuracy and reproducibility when preparing transfection complexes, prepare a dilution of your stock oligonucleotides, and pipet a higher volume of diluted stock.
The turnaround time varies depending on the level of purification and whether it is a custom order or not. Please see the approximate timetable below:
Standard purification (5 and 20 nmol), 4 business days
HPLC/in vivo ready (250 nmol), 15 business days
Custom mirVana Mimics and Inhibitors, 15 business days
Yes, please provide us with your unpublished miRNA sequence and we can synthesize a corresponding mirVana mimic or inhibitor by clicking on this link (www5.invitrogen.com/custom-genomic-products/tools/mirna/).
Negative control sequences require a confidential disclosure agreement while target sequences require prior proof of purchase for release.
For Research Use Only. Not for use in diagnostic procedures.
By clicking Submit, you acknowledge that you may be contacted by Fisher Scientific in regards to the feedback you have provided in this form. We will not share your information for any other purposes. All contact information provided shall also be maintained in accordance with our Privacy Policy.